The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Mylan makes generic drugs and the name brand companies are not investing in new drugs. 5, 6 or 7 years down the road more patents will expire and those drugs will go generic. People will want cheaper drugs in this economy. Mylan is building a new warehouse that is already 60% of capacity before the first wall went up.